Concept
Acute stress disorder
Related people (30)
Aurelio Muttoni
Aurelio Muttoni is full Professor and Head of the Structural Concrete Laboratory at the Ecole Polytechnique Fédérale de Lausanne (Switzerland). He received his diploma and PhD in civil engineering from the Swiss Federal Institute of Technology, Zurich, Switzerland, in 1982 and 1989, respectively.
His current teaching activities focus on the conceptual design of structures, theory and dimensioning of concrete structures as well as bridge design. His research group is active in the following domains: behaviour and design methods for structural concrete, conceptual design of innovative structures, shear in structural concrete, punching shear of slabs, nonlinear structural analysis including its reliability, bond between steel and concrete, aggregate interlocking, fatigue and influence of sustained loading on the concrete strength, mechanical behaviour and design concepts for ultra-high performance concrete, textile concrete and recycled concrete.
Aurelio Muttoni was the recipient of the Chester Paul Siess Award for Excellence in Structural Research in 2010 and the co-recipient of the Wason Medal for Most Meritorious Paper in 2014 of the American Concrete Institute. He is a member of the Presidium of fib (International Federation for Structural Concrete), several fib commissions and task groups and has been Project Team Leader for the second generation of EN 1992-1-1 (Eurocode for structural concrete).
Aurelio Muttoni is also cofounder and partner of the Muttoni & Fernández consulting office (www.mfic.ch). This office is active in the conceptual design, analysis and dimensioning of load-bearing structure in architecture and civil engineering constructions as well as consulting activities in the field of structural engineering.
Johan Auwerx
Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.